Kaemmerer Group created the InSynch newsletter for Medtronic to promote their neuromodulation therapies for chronic pain. The newsletter featured case studies from pain specialists on the cost-effectiveness of Medtronic's SynchroMed drug infusion system for treating chronic cancer pain. One case study compared the costs and patient outcomes of intravenous morphine versus treatment with the SynchroMed pump over six months. The pump provided better pain relief at a lower cost and improved the patient's quality of life in her final months.